These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 29631702)

  • 1. [Cyclophosphamide in idiopathic nephrotic syndrome: Outcome and outlook].
    Berkane M; Adarmouch L; Amine M; Bourrahouat A; Ait Sab I; Sbihi M
    Nephrol Ther; 2018 Apr; 14(2):85-90. PubMed ID: 29631702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporine in the treatment of childhood idiopathic steroid resistant nephrotic syndrome: a single centre experience in Nigeria.
    Ladapo TA; Esezobor CI; Lesi FE
    Pan Afr Med J; 2016; 25():258. PubMed ID: 28293374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous cyclophosphamide is the drug of choice for steroid dependent nephrotic syndrome.
    Bircan Z; Kara B
    Pediatr Int; 2003 Feb; 45(1):65-7. PubMed ID: 12654072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
    Chen SY; Wu CY; Tsai IJ; Tsau YK
    Nephrology (Carlton); 2010 Apr; 15(3):336-9. PubMed ID: 20470303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclophosphamide in steroid-dependent nephrotic syndrome.
    Azib S; Macher MA; Kwon T; Dechartres A; Alberti C; Loirat C; Deschênes G; Baudouin V
    Pediatr Nephrol; 2011 Jun; 26(6):927-32. PubMed ID: 21394465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of steroids, cyclosporin and cyclophos-phamide in steroid resistant idiopathic nephrotic syndrome.
    Hafeez F; Ahmad TM; Anwar S
    J Coll Physicians Surg Pak; 2005 Jun; 15(6):329-32. PubMed ID: 15924835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclophosphamide and rituximab in frequently relapsing/steroid-dependent nephrotic syndrome.
    Webb H; Jaureguiberry G; Dufek S; Tullus K; Bockenhauer D
    Pediatr Nephrol; 2016 Apr; 31(4):589-94. PubMed ID: 26525199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of idiopathic steroid-resistant nephrotic syndrome in children.
    Inaba A; Hamasaki Y; Ishikura K; Hamada R; Sakai T; Hataya H; Komaki F; Kaneko T; Mori M; Honda M
    Pediatr Nephrol; 2016 Mar; 31(3):425-34. PubMed ID: 26335197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes in idiopathic nephrotic syndrome: from childhood to adulthood.
    Skrzypczyk P; Panczyk-Tomaszewska M; Roszkowska-Blaim M; Wawer Z; Bienias B; Zajgzkowska M; Kilis-Pstrusinska K; Jakubowska A; Szczepaniak M; Pawlak-Bratkowska M; Tkaczyk M
    Clin Nephrol; 2014 Mar; 81(3):166-73. PubMed ID: 24361057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of cyclophosphamide therapy in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome.
    Cammas B; Harambat J; Bertholet-Thomas A; Bouissou F; Morin D; Guigonis V; Bendeddouche S; Afroukh-Hacini N; Cochat P; Llanas B; Decramer S; Ranchin B
    Nephrol Dial Transplant; 2011 Jan; 26(1):178-84. PubMed ID: 20610527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome.
    Sinha A; Gupta A; Kalaivani M; Hari P; Dinda AK; Bagga A
    Kidney Int; 2017 Jul; 92(1):248-257. PubMed ID: 28318625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome.
    Mendizábal S; Zamora I; Berbel O; Sanahuja MJ; Fuentes J; Simon J
    Pediatr Nephrol; 2005 Jul; 20(7):914-9. PubMed ID: 15891923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up after cyclophosphamide and cyclosporine-A therapy in steroid-dependent and -resistant nephrotic syndrome.
    Sümegi V; Haszon I; Bereczki C; Papp F; Túri S
    Pediatr Nephrol; 2008 Jul; 23(7):1085-92. PubMed ID: 18324421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of focal glomerulosclerosis with pulse steroids and oral cyclophosphamide.
    Hari P; Bagga A; Jindal N; Srivastava RN
    Pediatr Nephrol; 2001 Nov; 16(11):901-5. PubMed ID: 11685598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up after cyclophosphamide therapy in steroid-dependent nephrotic syndrome.
    Zagury A; de Oliveira AL; de Moraes CA; de Araujo Montalvão JA; Novaes RH; de Sá VM; Monteiro de Carvalho Dde B; Matuck T
    Pediatr Nephrol; 2011 Jun; 26(6):915-20. PubMed ID: 21399901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series.
    Maas RJ; Deegens JK; Beukhof JR; Reichert LJ; Ten Dam MA; Beutler JJ; van den Wall Bake AWL; Rensma PL; Konings CJ; Geerse DA; Feith GW; Van Kuijk WH; Wetzels JF
    Am J Kidney Dis; 2017 May; 69(5):637-646. PubMed ID: 28089478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children.
    Larkins N; Kim S; Craig J; Hodson E
    Arch Dis Child; 2016 Apr; 101(4):404-8. PubMed ID: 26289063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome.
    Gulati A; Sinha A; Gupta A; Kanitkar M; Sreenivas V; Sharma J; Mantan M; Agarwal I; Dinda AK; Hari P; Bagga A
    Kidney Int; 2012 Nov; 82(10):1130-5. PubMed ID: 22763815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroid resistant nephrotic syndrome is sustained remission attainable.
    Nammalwar BR; Vijaykumar M; Prahlad N; Jain DV
    Indian Pediatr; 2006 Jan; 43(1):39-43. PubMed ID: 16465005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.